The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Connor Serge Siversky - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: First one just to add to Josh's question on the investment activity in the U.K. I'm curious about behavioral health, some of the initiatives
that have been laid out by the NHS there. I'm wondering if you can provide any color as to what kind of momentum that space is
seeing in the U.K. in terms of funding from the NHS?
Question: Connor Serge Siversky - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: That's great color. Change in gears a little bit, thinking about the race to distribute the vaccine versus some of the emerging virus
of variants that we're seeing news flow on. Is there any commentary available from your operators, whether in the U.S. or elsewhere,
in regard to the take-up of the vaccinations by the health care workers and how quickly it's -- they're being distributed through the
facilities?
Question: Connor Serge Siversky - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Okay. And then one more quick one for me. Just looking at pro forma leverage ticked up a little bit. So I'm just wondering when you
consider the investment pipeline through the end of the year, maybe beyond if you're going to consider a different financing mix
for future acquisitions?
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: Yes. I wanted to touch on the NHS deal that you guys announced. And it seems like this is with a, I guess, a private operator within
NHS, I guess, how does that work out I guess, is it with NHS? Or was it a private operator? Or was this just on special segments that
they created?
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: And now is that corporate guarantee or that lease directly with that NHS? Or is it a subsidiary to NHS?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
FEBRUARY 04, 2021 / 4:00PM, MPW.N - Q4 2020 Medical Properties Trust Inc Earnings Call
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: Okay. And then, I guess, how big is an opportunity is it for you to continue to grow with NHS in the U.K.? I know that most of the
growth has been with private operators. I mean, there's an opportunity to make bigger investments with NHS?
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: Does NHS typically sell their real estate? I mean, I guess, do they own most of their own?
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: Okay. And then can you talk a little bit about the Swiss Medical Network deal. Did I hear that correctly, that was into the operator?
Or was there some real estate investment tied with that?
Question: Michael Albert Carroll - RBC Capital Markets, Research Division - Analyst
: Okay. Okay. And then I know that there was an opportunity when you fortunately did that deal to kind of consolidate and grow in
that market. I mean, have you started doing that yet? Or is there a near term opportunities to kind of start acquiring new properties
and grow that entire venture?
| 
